Evidence map›Paper›PMID 16852806›Full record

ArticleThe journal of physical chemistry. B2005

Interactions of membrane-active peptides with thick, neutral, nonzwitterionic bilayers.

Kandaswamy Vijayan, Dennis E Discher, Jyotsana Lal, Paul Janmey, Mark Goulian

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Infectious Disease: Connecting Innate Immunity to Biocidal Polymers.Materials science & engineering. R, Reports : a review journal · 2007
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kandaswamy VijayanDepartments of Physics, of Chemical and Biomolecular Engineering, and of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Dennis E Discher
Jyotsana Lal
Paul Janmey
Mark Goulian

Funding

Novel antibacterial agents resistant to inactivation by polyelectrolytesR01HL067286 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A · 2001 to 2010
$2.5M
Worm-like Micelles for Targeted Delivery and ImagingR21EB004000 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2004 to 2005
$348k
NHLBI NIH HHS R01 HL067286NHLBI NIH HHS R01 HL67286NIBIB NIH HHS R21 EB004000
6 · The paper itself

Abstract

Alamethicin is a well-studied channel-forming peptide that has a prototypical amphipathic helix structure. It permeabilizes both microbial and mammalian cell membranes, causing loss of membrane polarization and leakage of endogenous contents. Antimicrobial peptide-lipid systems have been studied quite extensively and have led to significant advancements in membrane biophysics. These studies have been performed on lipid bilayers that are generally charged or zwitterionic and restricted to a thickness range of 3-5 nm. Bilayers of amphiphilic diblock copolymers are a relatively new class of membranes that can have significantly different physicochemical properties compared with those of lipid membranes. In particular, they can be made uncharged, nonzwitterionic, and much thicker than their lipid counterparts. In an effort to extend studies of membrane-protein interactions to these synthetic membranes, we have characterized the interactions of alamethicin and several other membrane-active peptides with diblock copolymer bilayers. We find that although alamethicin is too small to span the bilayer, the peptide interacts with, and ruptures, thick polymer membranes.

Indexed as

AlamethicinCircular DichroismFluoresceinsHydrophobic and Hydrophilic InteractionsSpectrometry, FluorescenceWaterAlamethicinFluoresceinsfluorexonWater

Identifiers

PMID16852806
PMCPMC2532852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.